Table 2.

The number of circulating blood cells in control and DREAM bone marrow chimeric mice

WBC, 109/LNE, 109/LLY, 109/LMO, 109/LRBC, 109/LPLT, 109/LMPV, fL
WT 4.2 ± 1.3 0.7 ± 0.2 3.2 ± 1.5 0.1 ± 0.0 9.0 ± 1.3 1088 ± 167 7.6 ± 1.6 
HP DREAM KO 3.1 ± 0.7 0.7 ± 0.2 3.0 ± 0.5 0.1 ± 0.0 10.5 ± 1.4 1011 ± 178 7.4 ± 1.8 
Non-HP DREAM KO 3.3 ± 0.5 1.0 ± 0.3 3.8 ± 0.8 0.1 ± 0.0 9.9 ± 1.0 1054 ± 159 8.3 ± 1.3 
DREAM KO 3.2 ± 0.6 0.6 ± 0.2 2.7 ± 0.7 0.1 ± 0.0 9.5 ± 1.0 889 ± 110 7.3 ± 1.5 
WBC, 109/LNE, 109/LLY, 109/LMO, 109/LRBC, 109/LPLT, 109/LMPV, fL
WT 4.2 ± 1.3 0.7 ± 0.2 3.2 ± 1.5 0.1 ± 0.0 9.0 ± 1.3 1088 ± 167 7.6 ± 1.6 
HP DREAM KO 3.1 ± 0.7 0.7 ± 0.2 3.0 ± 0.5 0.1 ± 0.0 10.5 ± 1.4 1011 ± 178 7.4 ± 1.8 
Non-HP DREAM KO 3.3 ± 0.5 1.0 ± 0.3 3.8 ± 0.8 0.1 ± 0.0 9.9 ± 1.0 1054 ± 159 8.3 ± 1.3 
DREAM KO 3.2 ± 0.6 0.6 ± 0.2 2.7 ± 0.7 0.1 ± 0.0 9.5 ± 1.0 889 ± 110 7.3 ± 1.5 

Blood cells from WT control, DREAM KO control, and their bone marrow chimeric mice (HP and Non-HP DREAM KO) were counted using an automated hematology analyzer (ADVIA 120; Siemens AG). Data represent the mean ± SD (n = 6 mice per group).

HP, hematopoietic; Non-HP, nonhematopoietic. Other abbreviations are explained in Table 1.

or Create an Account

Close Modal
Close Modal